![]() |
市场调查报告书
商品编码
1930034
骨填充材料市场规模、占有率、成长及全球产业分析:按类型、应用和地区划分的洞察与预测(2025-2034)Bone Void Fillers Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2025-2034 |
||||||
全球骨填充材料市场预计在2025年达到37.3亿美元,并在2026年达到39.7亿美元。报告显示,该市场预计将持续稳定成长,到2034年达到67.4亿美元,在预测期(2026-2034年)内复合年增长率(CAGR)为6.8%。
北美地区在2025年将占全球市场47.3%的占有率,这主要得益于该地区骨科手术量大以及主要生产商的强大影响力。
骨填充物(BVF)是一种生物相容性、生物活性、可吸收且具有骨传导性的材料,用于填充四肢、骨盆和脊椎等部位的骨缺损。这些材料能够提供结构稳定性并促进骨再生,在骨科、创伤和脊椎手术中发挥至关重要的作用。
市场驱动因素
骨病变和骨折的日益增加
骨肿瘤、骨髓炎、骨折和创伤性损伤的盛行率不断上升是推动市场成长的主要因素。全球人口快速老化,导致骨质疏鬆症和骨折风险增加,进一步加速了对骨填充物的需求。这些产品广泛用于治疗慢性骨髓炎,而释放抗生素的填充物已显示出改善临床疗效的效果。
合成骨填充材料的日益普及
合成填充材料,如硫酸钙和磷酸三钙,因其诸多优势而迅速普及,包括高度无菌、供应无限、降低供体部位併发症风险以及与人体骨骼化学成分相似。 2020年,BONESUPPORT AB公司的CERAMENT产品获得FDA批准,进一步推动了合成填充材料的全球应用。
此外,可释放抗生素的骨填充材料兼具抗菌和骨传导的双重功效,可降低骨科感染的发生率,并进一步促进市场扩张。
市场趋势
对可释放抗生素填充材料的日益关注
影响市场发展的关键趋势之一是人们对用于预防术后感染的可释放抗生素的骨填充材料的兴趣日益浓厚。 2022年,BONESUPPORT AB的抗生素预混填充剂获得监管部门批准,Elute Inc.的妥布霉素预混EP颗粒获得FDA批准进行临床试验。预计这些创新将在预测期内显着推动市场成长。
市场限制因子
儘管成长前景强劲,但由于临床应用限制和骨缺损填充剂使用不广泛,市场仍面临挑战。组织反应、骨形成不完全、感染和产品破损等风险限制了部分地区的采用。
此外,FDA的产品召回事件,例如2021年OSTEOVATION RMX的召回,对市场信心造成了负面影响。自体移植和异体移植等传统外科技术的持续广泛应用进一步限制了市场渗透率。
按类型
脱矿骨基质 (DBM) 细分市场占最大的市场占有率,预计由于其丰富的供体来源、更快的癒合速度和更少的併发症,将继续保持其主导地位。
硫酸钙细分市场预计将以最高的复合年增长率成长,这主要归功于其抗菌特性以及在骨髓炎治疗中日益广泛的应用。胶原蛋白基质填充剂也因其易于使用和快速恢復而备受关注。
依型态
到 2025 年,糊状填充剂将占市场主导地位,约占 33% 的市场占有率。这主要得益于其在脊椎和骨科手术中的高应用率。糊状和颗粒状填充剂也因其生物相容性的提高和良好的临床效果而不断增长。
依最终使用者划分
到 2026 年,医院将占最大的市场占有率,达到 54.91%,这主要得益于其高骨科手术量和先进的手术基础设施。预计专科诊所在预测期内也将稳定成长。
The global bone void fillers market was valued at USD 3.73 billion in 2025 and is projected to reach USD 3.97 billion in 2026. According to the report, the market is expected to grow steadily and attain a value of USD 6.74 billion by 2034, registering a compound annual growth rate (CAGR) of 6.8% during the forecast period (2026-2034).
In 2025, North America dominated the global market with a share of 47.3%, supported by a high volume of orthopedic procedures and the strong presence of leading manufacturers.
Bone Void Fillers (BVFs) are biocompatible, bioactive, absorbable, and osteoconductive materials used to fill bone gaps in areas such as extremities, pelvis, and the spine. These materials provide structural stability and promote bone regeneration, making them essential in orthopedic, trauma, and spinal surgeries.
Market Drivers
Rising Burden of Bone Diseases and Fractures
The increasing prevalence of bone tumors, osteomyelitis, fractures, and trauma injuries is a major factor driving market growth. A rapidly aging global population, which is more prone to osteoporosis and fractures, is further accelerating demand for bone void fillers. These products are widely used in the treatment of chronic osteomyelitis, where antibiotic-eluting fillers have shown improved clinical outcomes.
Growing Adoption of Synthetic Bone Void Fillers
Synthetic fillers such as calcium sulfate and tri-calcium phosphate are witnessing strong adoption due to advantages like high sterility, unlimited supply, reduced donor-site morbidity, and chemical similarity to human bone. In 2020, BONESUPPORT AB received FDA approval for CERAMENT, strengthening the adoption of synthetic fillers globally.
Additionally, antibiotic-eluting bone void fillers offer combined antimicrobial and osteoconductive benefits, reducing orthopedic infection rates and driving further market expansion.
Market Trends
Increasing Focus on Antibiotic-Eluting Fillers
One of the key trends shaping the market is the growing focus on antibiotic-eluting bone void fillers to prevent post-surgical infections. In 2022, BONESUPPORT AB received regulatory approvals for antibiotic-mixed fillers, while Elute, Inc. obtained FDA authorization for clinical trials of EP Granules with Tobramycin. Such innovations are expected to significantly boost market growth during the forecast period.
Market Restraints
Despite strong growth prospects, the market faces challenges due to clinical limitations and under-penetration of bone void fillers. Risks such as adverse tissue reactions, incomplete bone formation, infections, and product breakage have limited adoption in some regions.
Moreover, FDA product recalls, such as the recall of OSTEOVATION RMX in 2021, have negatively impacted market confidence. Traditional procedures like autografts and allografts remain widely used, further restricting market penetration.
By Type
The demineralized bone matrix (DBM) segment held the largest market share and is expected to maintain its dominance due to abundant donor availability, faster healing, and reduced complications.
The calcium sulfate segment is projected to grow at the fastest CAGR due to its antibiotic properties and increasing use in osteomyelitis treatment. Collagen matrix fillers are also gaining traction because of ease of use and faster recovery.
By Form
The putty segment dominated the market in 2025, accounting for approximately 33% share, driven by high adoption in spinal and orthopedic procedures. Paste and granule forms are also expanding due to improved biocompatibility and favorable clinical outcomes.
By End User
Hospitals accounted for the largest market share, 54.91% in 2026, due to the high volume of orthopedic surgeries and availability of advanced surgical infrastructure. Specialty clinics are also expected to grow steadily during the forecast period.
Competitive Landscape
Key players include Zimmer Biomet, Stryker, DePuy Synthes, BONESUPPORT AB, Biocomposites, and Collagen Matrix. Market leaders are focusing on product launches, mergers & acquisitions, and geographic expansion to strengthen their market position.
Conclusion
In conclusion, the bone void fillers market is set for steady growth, increasing from USD 3.73 billion in 2025 to USD 6.74 billion by 2034. Growth is driven by rising orthopedic procedures, increasing bone disease burden, and strong innovation in synthetic and antibiotic-eluting fillers. While clinical risks and product recalls remain challenges, continuous R&D, regulatory approvals, and expanding applications are expected to sustain long-term market expansion.
Segmentation By Type
By Form
By End-user
By Region